Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Epinephrine Bitartrate Research Workflows
2026-08-22
Build reproducible adrenergic signaling assays with Epinephrine Bitartrate across receptor activation, cellular function, and translational workflows. Learn how to exploit its broad α- and β-receptor activity while controlling stock stability, dose selection, vehicle effects, and supply-sensitive experimental design.
-
Spatially Concentrated ABEs Correct PLP1 Mutations
2026-08-22
A 2026 Nucleic Acids Research study introduces spatially concentrated adenine base editors that improve PLP1 mutation correction in oligodendrocytes without relying on greater intrinsic TadA* catalytic activity. By combining SunTag-mediated recruitment with a compact Cas9 variant suitable for AAV delivery, the authors link improved editing to restored PLP localization and myelination-related phenotypes.
-
DMG-PEG2000-NH2: From Linker to Translation
2026-08-21
A mechanistic and translational analysis of DMG-PEG2000-NH2 as a reactive lipid–PEG platform, connecting amide chemistry, LNP formulation, siRNA encapsulation, and structure–activity lessons from optimized sulfonamides.
-
Mithramycin A as a Transcriptional Probe
2026-08-20
Mithramycin A is an anticancer antibiotic that converts G-C-rich DNA recognition into a powerful framework for studying transcription, c-myc, differentiation, and pathway causality. This article connects its assay logic with the miR-24-3p/Sp1/PI3K findings while defining appropriate boundaries for cancer and cardiac research.
-
Deferasirox Fe3+ Chelate in Lysosome Research
2026-08-20
Deferasirox Fe3+ chelate offers a chemically defined way to investigate ferric-iron biology alongside lysosomal stress. This article connects the compound to TCF25-driven ferritinophagy while emphasizing assay controls, chemical-form interpretation, and research limitations.
-
Dibutyryl-cAMP, Sodium Salt in Signaling Assays
2026-08-19
Dibutyryl-cAMP, sodium salt provides a direct, cell-permeable route for probing cAMP–PKA biology in endothelial, immune, and neuronal models. This workflow-focused guide connects DBcAMP sodium salt to reproducible dose-response design, inflammation modulation studies, and hypothesis testing inspired by a murine lupus lung-injury study.
-
Foretinib: From Kinase Mechanism to Translational Insight
2026-08-19
Foretinib (GSK1363089) offers a useful translational research framework for connecting Met and VEGFR pathway inhibition with tumor cell growth inhibition, motility, invasion, and metastasis. This article shows how to pair mechanistic assays with response metrics that distinguish proliferative arrest from cell death, improving interpretation across cell-based and xenograft models.
-
Concanavalin A Targets Conserved Coronavirus Glycans
2026-08-18
The reference study identifies concanavalin A as a broad coronavirus entry inhibitor that recognizes conserved high-mannose N-glycans near the spike S2′ cleavage site. Its combined fusion, pseudovirus, authentic-virus, biochemical, and animal experiments indicate that glycan shielding can prevent spike activation, while also defining important limits for translating morphology-focused imaging into mechanistic glycan analysis.
-
WNT5a/GSK3/β-Catenin in FAP Adipogenesis
2026-08-18
The reference study identifies the WNT5a/GSK3/β-catenin axis as a central regulator of adipogenic drift in skeletal muscle fibro/adipogenic progenitors. By combining pharmacological perturbation, mass cytometry, transcriptomics, and mouse models, it links pathway modulation to reduced fat infiltration and improved support of muscle satellite cell differentiation.
-
Neuromedin S (rat): Protocol and QC Guide
2026-08-17
Neuromedin S (rat) provides a chemically defined rat peptide input for controlled studies of neuromedin U receptor signaling and related GPCR/G protein signaling workflows. It should be used for scientific research only, not as a diagnostic or therapeutic agent, and the available dossier does not establish assay potency or in vivo outcomes.
-
Probenecid Workflows for Transporter Research
2026-08-17
Probenecid enables controlled studies of MRP-mediated drug efflux, pannexin-1 signaling, and injury-associated inflammatory responses. This guide translates those mechanisms into practical oncology, neuroscience, and exploratory CD8+ T-cell metabolism workflows while emphasizing vehicle controls, orthogonal readouts, and assay-specific troubleshooting.
-
Butylated Hydroxyanisole (BHA) for ROS Assays
2026-08-16
Use Butylated hydroxyanisole as a controlled antioxidant variable in ROS detection, cellular protection, and oxidative stress research—not as a standalone proof of mechanism. This workflow emphasizes solvent controls, fresh preparations, orthogonal readouts, and assay-design lessons from stereochemistry-focused peptide research.
-
Carbohydrate-Decorated Nanoparticles Target Macrophages
2026-08-15
The reference study developed biodegradable nanoparticles whose carbohydrate surface chemistry improved macrophage uptake and reporter-gene delivery. Mannose and dextran produced particularly informative targeting and transfection profiles, showing why nanoparticle composition should be optimized alongside cargo type and cellular readouts.
-
E-64 in Salt-Sensitive Hypertension: What the Study Found
2026-08-14
The reference study tested chronic systemic E-64 treatment in Dahl salt-sensitive rats exposed to a high-salt diet, integrating blood pressure, renal injury, podocyte calcium, and cathepsin measurements. Although the intervention engaged the cathepsin system, it did not prevent hypertension, albuminuria, or altered basal podocyte calcium under the reported conditions, highlighting the context dependence of cysteine protease inhibition.
-
Azithromycin B1398 for Reliable Cell Assays
2026-08-14
Learn how Azithromycin (SKU B1398) can be integrated into cell viability, proliferation, antimicrobial resistance, and infection-model workflows without confusing antimicrobial activity with mammalian cytotoxicity. This scenario-based guide covers formulation, controls, concentration selection, interpretation, and practical product-selection criteria.